(Total Views: 732)
Posted On: 10/12/2020 8:37:09 AM
Post# of 148899
The FDA does not decide whether or not to stop the trial. That is the DSMC. They are completely independent of the FDA. Also we don't know if Nader has asked to unblind the trial and take a penalty.
Statistical significance is reached at approximately 22/23. Where did you get your numbers?
Regeneron and Lilly are NOT for severe/critical. They are for mild/moderate early stage disease only and they are NOT competition. Also, they have very few doses available.
Statistical significance is reached at approximately 22/23. Where did you get your numbers?
Regeneron and Lilly are NOT for severe/critical. They are for mild/moderate early stage disease only and they are NOT competition. Also, they have very few doses available.
(1)
(0)Scroll down for more posts ▼
